You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Neurological conditions
  5. Epilepsy

Cannabis-based medicinal products

  • NICE guideline
  • Reference number: NG144
  • Published:  11 November 2019
  • Last updated:  22 March 2021
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History
Download (PDF)

Evidence reviews – November 2019

The following documents contain the evidence that was used to develop these recommendations:

  • Intractable nausea and vomiting
  • Chronic pain
  • Spasticity
  • Epilepsy
  • Prescribing cannabis-based medicinal products
  • Appendix 1: Expert witness report

This page was last updated: 11 November 2019

Back to top